Discovery of the seeds for plant-derived molecular-targeted agents with a focus on microtubule dynamics
Project/Area Number |
26860069
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Natural medicines
|
Research Institution | Tokyo University of Pharmacy and Life Science |
Principal Investigator |
|
Project Period (FY) |
2014-04-01 – 2018-03-31
|
Project Status |
Completed (Fiscal Year 2017)
|
Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2017: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2016: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2015: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2014: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
|
Keywords | 腫瘍細胞毒性 / アポトーシス / 微小管ダイナミクス / 分子標的 / 細胞周期 / チューブリン |
Outline of Final Research Achievements |
The alcoholic extracts of three crude drugs [the roots and rhizomes of Saposhnikovia divaricata (Umbelliferae), the leaves of Thujopsis dolabrata, and the barks of Marsdenia cundurango], three Amaryllidaceae plants (Lycoris radiata, Galanthus elwesii, and Haemanthus multiflorus), a Ranunculaceae plant (Helleborus foetidus), and a Liliaceae plant (Ornithogalum saundersiae), were evaluated for their cytotoxic activity against HL-60 human leukemia cells. As a result of bioassay-guided fractionation of the extracts, a chromon derivative from S. divaricata, a pregnane glycoside from the barks of M. cundurango, a bufadienolide derivative (HF-1) and anemonin from H. foetidus, a cholestane glycoside (OS-1) from O. saundersiae were obtained as active substances, and all of them induced apoptosis in HL-60 cells. HF-1, anemonin, and OS-1 arrested cell cycle progression in G2/M phase. Anemonin showed microtuble assembly in A549 human lung cancer cells by immunofluoresence microscopy.
|
Report
(5 results)
Research Products
(19 results)